TY - JOUR
T1 - Echocardiography-Guided Interventions
AU - Silvestry, Frank E.
AU - Kerber, Richard E.
AU - Brook, Michael M.
AU - Carroll, John D.
AU - Eberman, Karen M.
AU - Goldstein, Steven A.
AU - Herrmann, Howard C.
AU - Homma, Shunichi
AU - Mehran, Roxana
AU - Packer, Douglas L.
AU - Parisi, Alfred F.
AU - Pulerwitz, Todd
AU - Seward, James Bernard
AU - Tsang, Teresa S.M.
AU - Wood, Mark A.
N1 - Funding Information:
Frank E. Silvestry is a consultant for Biosense Webster (Diamond Bar, CA), formerly Siemens Medical Systems (Erlangen, Germany). John D. Carroll is a consultant and lecturer for and a recipient of royalties from Philips Healthcare (Andover, MA), a consultant for Biosense Webster, and a consultant for W. L. Gore & Associates (Newark, DE). Howard C. Herrmann is a consultant for Biosense Webster and AGA Medical (Plymouth, MN) and has received research funding from Edwards Lifesciences (Irvine, CA), Evalve (Menlo Park, CA), and W. L. Gore & Associates. Douglas L. Packer has received research support from Siemens Acuson (Mountain View, CA), is a past advisory board member for Siemens Acuson, and is a current scientific advisory board member for Siemens. Richard E. Kerber, Michael M. Brook, Karen M. Eberman, Steven A. Goldstein, Shunichi Homma, Roxana Mehran, Alfred F. Parisi, Todd Pulerwitz, James Bernard Seward, Teresa S. M. Tsang, and Mark A. Wood have no disclosures to report.
PY - 2009/3
Y1 - 2009/3
N2 - A major advantage of echocardiography over other advanced imaging modalities (magnetic resonance imaging, computed tomographic angiography) is that echocardiography is mobile and real time. Echocardiograms can be recorded at the bedside, in the cardiac catheterization laboratory, in the cardiovascular intensive care unit, in the emergency room-indeed, any place that can accommodate a wheeled cart. This tremendous advantage allows for the performance of imaging immediately before, during, and after various procedures involving interventions. The purpose of this report is to review the use of echocardiography to guide interventions. We provide information on the selection of patients for interventions, monitoring during the performance of interventions, and assessing the effects of interventions after their completion. In this document, we address the use of echocardiography in commonly performed procedures: transatrial septal catheterization, pericardiocentesis, myocardial biopsy, percutaneous transvenous balloon valvuloplasty, catheter closure of atrial septal defects (ASDs) and patent foramen ovale (PFO), alcohol septal ablation for hypertrophic cardiomyopathy, and cardiac electrophysiology. A concluding section addresses interventions that are presently investigational but are likely to enter the realm of practice in the very near future: complex mitral valve repairs, left atrial appendage (LAA) occlusion devices, 3-dimensional (3D) echocardiographic guidance, and percutaneous aortic valve replacement. The use of echocardiography to select and guide cardiac resynchronization therapy has recently been addressed in a separate document published by the American Society of Echocardiography and is not further discussed in this document. The use of imaging techniques to guide even well-established procedures enhances the efficiency and safety of these procedures.
AB - A major advantage of echocardiography over other advanced imaging modalities (magnetic resonance imaging, computed tomographic angiography) is that echocardiography is mobile and real time. Echocardiograms can be recorded at the bedside, in the cardiac catheterization laboratory, in the cardiovascular intensive care unit, in the emergency room-indeed, any place that can accommodate a wheeled cart. This tremendous advantage allows for the performance of imaging immediately before, during, and after various procedures involving interventions. The purpose of this report is to review the use of echocardiography to guide interventions. We provide information on the selection of patients for interventions, monitoring during the performance of interventions, and assessing the effects of interventions after their completion. In this document, we address the use of echocardiography in commonly performed procedures: transatrial septal catheterization, pericardiocentesis, myocardial biopsy, percutaneous transvenous balloon valvuloplasty, catheter closure of atrial septal defects (ASDs) and patent foramen ovale (PFO), alcohol septal ablation for hypertrophic cardiomyopathy, and cardiac electrophysiology. A concluding section addresses interventions that are presently investigational but are likely to enter the realm of practice in the very near future: complex mitral valve repairs, left atrial appendage (LAA) occlusion devices, 3-dimensional (3D) echocardiographic guidance, and percutaneous aortic valve replacement. The use of echocardiography to select and guide cardiac resynchronization therapy has recently been addressed in a separate document published by the American Society of Echocardiography and is not further discussed in this document. The use of imaging techniques to guide even well-established procedures enhances the efficiency and safety of these procedures.
KW - 3-dimensional echocardiography
KW - Alcohol septal ablation
KW - Atrial septal defect
KW - Cardiac electrophysiology
KW - Cardiac ultrasound
KW - Congenital heart disease
KW - Echocardiography
KW - Hypertrophic cardiomyopathy
KW - Intracardiac echocardiography
KW - Left atrial appendage occlusion
KW - Myocardial biopsy
KW - Parent foramen ovale
KW - Percutaneous transvenous balloon valvuloplasty
KW - Pericardiocentesis
KW - Transesophageal echocardiography
KW - Transseptal catheterization
UR - http://www.scopus.com/inward/record.url?scp=61549089048&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=61549089048&partnerID=8YFLogxK
U2 - 10.1016/j.echo.2008.12.013
DO - 10.1016/j.echo.2008.12.013
M3 - Article
C2 - 19258174
AN - SCOPUS:61549089048
VL - 22
SP - 213
EP - 231
JO - Journal of the American Society of Echocardiography
JF - Journal of the American Society of Echocardiography
SN - 0894-7317
IS - 3
ER -